entity

Complement C1q

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Complement C1q: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections
9Hypotheses
6Analyses
8Outgoing
1Incoming
11Experiments
8Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Complement C1q Subunit A Protein

protein · 897 words

Outgoing (8)

TargetRelationTypeStr
CR3 Receptorinteracts_withreceptor0.90
synapse losscausesphenotype0.90
Complement C3activatesprotein0.80
synaptic losscausesphenotype0.70
synapse depositioncausesphenotype0.70

Incoming (1)

SourceRelationTypeStr
TREM2binds_togene0.90

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Complement C1q-Mediated Synaptic Pruning Drives Early Cognit 0.769 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
Complement C1q Mimetic Decoy Therapy 0.695 neurodegeneration Synaptic pruning by microglia in early A
Complement C1q/C3 Inhibition to Prevent Synaptodendritis in 0.690 neurodegeneration Test
Complement C1QA Spatial Gradient in Cortical Layers 0.678 alzheimers SEA-AD Gene Expression Profiling — Allen
Complement C1q Subtype Switching 0.665 neurodegeneration 4R-tau strain-specific spreading pattern
Complement C1QA Inhibition Synergizes with PV Interneuron Mo 0.659 neurodegeneration What molecular mechanisms underlie the d
Complement C1q/C3 Blockade for Alzheimer's Disease 0.619 neurodegeneration Test
Complement C1q Suppression as Mechanism Linking Exercise Pla 0.560 neurodegeneration What are the specific circulating factor
Complement C1q Blockade for Selective Pruning Prevention 0.000 - Synaptic pruning by microglia in early A

Mentioning Analyses (6)

Scientific analyses that reference this entity

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

neuroinflammation | 2026-04-16 | 5 hypotheses Top: 0.597

Why have numerous phase 3 clinical trials failed despite advances in understandi

neurodegeneration | 2026-04-16 | 0 hypotheses

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.586

How does APOE4's beneficial immune function reconcile with its established role

neurodegeneration | 2026-04-14 | 0 hypotheses

How does sevoflurane-induced NF-κB activation specifically trigger complement ca

neuroinflammation | 2026-04-08 | 5 hypotheses Top: 0.658

Experiments (11)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
C1q neutralization experiment validation perioperative neurocognitive d 0.900 0.00 rats proposed N/A
scRNA-seq analysis of human atherosclerotic plaques exploratory Atherosclerosis 0.900 0.00 human atherosclerotic plaque s proposed N/A
Sevoflurane-induced neurotoxicity (SIN) model in rats validation perioperative neurocognitive d 0.900 0.00 rats proposed N/A
Machine learning-based identification of C1Q hub genes exploratory Atherosclerosis 0.900 0.00 Human bulk RNA sequencing data proposed N/A
Gene expression validation in apoE-/- mice validation Atherosclerosis 0.850 0.00 apoE-/- mice proposed N/A
ox-LDL treatment of RAW264.7 macrophages exploratory Atherosclerosis 0.850 0.00 RAW264.7 macrophages proposed N/A
Validation of hub genes in ox-LDL treated RAW264.7 macrophages exploratory Atherosclerosis 0.800 0.00 RAW264.7 macrophages proposed N/A
Validation of hub genes in apoE-/- atherosclerotic mice validation Atherosclerosis 0.800 0.00 apoE-/- mice proposed N/A
s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engin falsification Neuroinflammation 0.400 0.50 mouse proposed $200,000
Proposed experiment from debate on Synaptic pruning by microglia in ea falsification Alzheimer's Disease 0.400 0.50 mouse proposed $200,000
Experiment: Autoimmune Hypothesis Testing in AD clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Prolonged anesthesia induces neuroinflammation and complement-mediated microglia [PMID:36600274] Xu F, Han L, Wang Y, Deng D, Ding Y, Zha BMC Med 2023 2
Perivascular cells induce microglial phagocytic states and synaptic engulfment v [PMID:36747024] De Schepper S, Ge JZ, Sierksma A, Crowle Nat Neurosci 2023 2
An integrative analysis of single-cell and bulk transcriptome and bidirectional [PMID:38179058] Cui HK, Tang CJ, Gao Y, Li ZA, Zhang J, Front Immunol 2023 2
Young adult microglial deletion of C1q reduces engulfment of synapses and preven [PMID:41000995] Petrisko TJ, Chu SH, Gomez-Arboledas A, bioRxiv : the preprint server 2025 1
The Role of Complement in Synaptic Pruning and Neurodegeneration. [PMID:34595138] Gomez-Arboledas A, Acharya MM, Tenner AJ ImmunoTargets and therapy 2021 1
Early complement genes are associated with visual system degeneration in multipl [PMID:31289819] Fitzgerald KC, Kim K, Smith MD, Aston SA Brain 2019 1
Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an [PMID:41396874] Unknown Brain : a journal of neurology 2026 0
Molecular Insights Into Canine Hepatocellular Carcinoma: A Cross-Species Transcr [PMID:41664952] Arif M, Hasan MN, Nozaki N, Ide Y, Akiya Mol Carcinog 2026 0
Phosphoproteomics uncovers a neuroimmune perspective on trigeminal neuralgia: se [PMID:41853292] Zhai X, Lin X, Zhang L, Ren Y, Miao H, M Frontiers in immunology 2026 0
Proteomic Signature in Men with Central Serous Chorioretinopathy. [PMID:41641862] Chambon C, Picard E, Zola M, Aichedo S, Journal of proteome research 2026 0
Machine Learning and Blood-Targeted Proteomics Enable Early Prediction and Etiol [PMID:41683823] Starodubtseva N, Tokareva A, Kononikhin International journal of molec 2026 0
Club cell RhoA activation amplifies allergic airway inflammation by regulating e [PMID:41633491] Tu W, Wu M, Wan R, Alphonse M, Gu W, Gho The Journal of allergy and cli 2026 0
Identifying the hub genes in macrophage infiltration and verifying of the role o [PMID:41730938] Tang L, Xu Y, Nong Z, Li F, Pan L Scientific reports 2026 0
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] ["Sanadgol N", "Abedi M", "Hashemzaei M" Journal of nanobiotechnology 2025 0
C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of [PMID:38278523] ["Angela Gomez-Arboledas", "Maria I Fons Alzheimer's & dementia : t 2024 0
The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and resc [PMID:39129007] Chae S, Lee HJ, Lee HE, Kim J, Jeong YJ, Journal of neuroinflammation 2024 0
Identification of crosstalk genes and immune characteristics between Alzheimer's [PMID:39188714] An W, Zhou J, Qiu Z, Wang P, Han X, Chen Frontiers in immunology 2024 0
Single-cell RNA sequencing reveals distinct immunology profiles in human keloid. [PMID:35990663] ["Feng C", "Shan M", "Xia Y", "Zheng Z", Frontiers in immunology 2022 0
[WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective [PMID:35168268] Wieschollek S, Forster S, Megerle K Handchirurgie, Mikrochirurgie, 2022 0
Evaluation method for cell-free in situ tissue-engineered vasculature monitoring [PMID:35436313] ["Matsumura G", "Isayama N", "Sato H"] PloS one 2022 0

Debates (8)

Multi-agent debates referencing this entity

While the study demonstrates both NF-κB pathway activation and increased C1qa ex

closed · Rounds: 4 · Score: 0.74 · 2026-04-21

There's a clear disconnect between improved mechanistic understanding of AD and

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

The abstract reports that Alectinib binds C1q with high affinity, but this is me

closed · Rounds: 4 · Score: 0.94 · 2026-04-16

This study shows APOE4 carriers have enhanced beneficial innate immune responses

closed · Rounds: 4 · Score: 0.60 · 2026-04-16

The abstract shows TYROBP deficiency is neuroprotective despite being required f

closed · Rounds: 4 · Score: 0.56 · 2026-04-15

How do peripheral immune system alterations influence CNS pathology and neurodeg

closed · Rounds: 4 · Score: 0.76 · 2026-04-12

How do peripheral immune system alterations influence CNS pathology and neurodeg

closed · Rounds: 4 · Score: 0.78 · 2026-04-12

How do peripheral immune system alterations influence CNS pathology and neurodeg

closed · Rounds: 4 · Score: 0.50 · 2026-04-11

Related Research

Hypotheses and analyses mentioning Complement C1q in their description or question text

Complement C1QA Inhibition Synergizes with PV Interneuron Modulation

Score: 0.659 · neurodegeneration · 2026-04-13

## Mechanistic Overview Complement C1QA Inhibition Synergizes with PV Interneuron Modulation starts from the claim that

Complement C1q/C3 Blockade for Alzheimer's Disease

Score: 0.619 · neurodegeneration · 2026-05-06

Microglia-mediated complement activation (C1q, C3) leads to excessive synaptic pruning in AD. Tau pathology sensitizes n

Complement C1q Suppression as Mechanism Linking Exercise Plasma to PV Interneuro

Score: 0.560 · neurodegeneration · 2026-04-14

## Mechanistic Overview Complement C1q Suppression as Mechanism Linking Exercise Plasma to PV Interneuron Protection sta

Complement C1q Blockade for Selective Pruning Prevention

Score: 0.000 · unknown disease · 2026-04-28

A selective C1q inhibitor that only blocks pathological complement tagging while preserving physiological pruning could